Medical device manufacturers need more time.
Industry leaders came together on 2-3 May to provide feedback to the US Environmental Protecion Agency during public hearings on draft ethylene oxide (EtO) guidelines
‘We Need More Time‘: Medtech Groups Testify Before EPA On ETO Emissions Regulation
Medtech groups call for extended commentary and compliance periods for two new EtO regulations from the EPA.
More from United States
More from North America
• By
Health and Human Services Secretary Robert F. Kennedy Jr. emphasized administrative cost reductions and defended budget decisions during a Senate hearing on HHS funding. Some senators, however, expressed concerns over the impacts spending cuts had on essential health programs.
• By
During his testimony before US senators on the impact of tariffs on critical supply chains, AdvaMed’s Scott Whitaker said the Trump tariffs could jeopardize America’s preeminence in medtech. Other industry experts echoed similar concerns.
• By
In Vivo spoke to the previous commissioner of the US FDA about recent ongoings at the agency, and where he believes policy should be directed for patient and industry benefit.